Keyword: Flemming Ornskov


Shire to Acquire Baxalta for $32 Billion

12.01.2016 - In a deal worth around $32 billion, Irish drug maker Shire – headquartered in Dublin but managed from Boston, Massachusetts – has agreed a takeover of US biopharmaceutical company...


Shire to Buy Biotech Firm Dyax

04.11.2015 - Ireland-based and London-listed drugmaker Shire has agreed what is being called a “defensive” deal to buy US biotech firm Dyax, which has a breakthrough drug said to threaten one...


Shire Boosts Eye Business with $160 Million SARcode Buy

25.03.2013 - Shire is to buy privately owned U.S. biotech firm SARcode Bioscience, paying $160 million upfront to win rights to a new drug in late-stage development for dry eye diseases. The...